These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 263885)

  • 1. In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents.
    Lewis VJ; Thacker WL; Shepard CC; McDade JE
    Antimicrob Agents Chemother; 1978 Mar; 13(3):419-22. PubMed ID: 263885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of antimicrobial agents on Legionnaires disease bacterium.
    Thornsberry C; Baker CN; Kirven LA
    Antimicrob Agents Chemother; 1978 Jan; 13(1):78-80. PubMed ID: 626494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV.
    Saravolatz LD; Pohlod DJ; Quinn EL
    Scand J Infect Dis; 1980; 12(3):215-9. PubMed ID: 7433921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopy of the pathology and chemotherapy of Legionella pneumophila infection in the chick embryo.
    Tzianabos AO; Rodgers FG
    Zentralbl Bakteriol; 1989 Oct; 271(4):466-74. PubMed ID: 2818797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of erythromycin in treatment of Legionella micdadei pneumonia.
    Rudin JE; Evans TL; Wing EJ
    Am J Med; 1984 Feb; 76(2):318-20. PubMed ID: 6607673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and chemotherapy of experimental Legionella pneumophila infection in the chick embryo.
    Tzianabos AO; Rodgers FG
    Zentralbl Bakteriol; 1989 Sep; 271(3):293-303. PubMed ID: 2803457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.
    Edelstein PH
    Antimicrob Agents Chemother; 1991 Jan; 35(1):5-9. PubMed ID: 2014980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of imipenem on Legionella pneumophila, with a note on the treatment of two cases.
    Farrell ID; Barker J; Chiodini PL; Hutchison JG; Geddes AM
    J Antimicrob Chemother; 1985 Jul; 16(1):61-5. PubMed ID: 3862660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin.
    Fitzgeorge RB; Baskerville A; Featherstone AS
    Lancet; 1986 Mar; 1(8479):502-3. PubMed ID: 2869238
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy of experimental airborne Legionnaires' disease.
    Gibson DH; Fitzgeorge RB; Baskerville A
    J Infect; 1983 Nov; 7(3):210-7. PubMed ID: 6663081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial chemotherapy for legionnaires' disease: a review.
    Edelstein PH
    Clin Infect Dis; 1995 Dec; 21 Suppl 3():S265-76. PubMed ID: 8749675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.
    Edelstein PH; Calarco K; Yasui VK
    Am Rev Respir Dis; 1984 Nov; 130(5):849-56. PubMed ID: 6333840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of severe respiratory infection. Legionella pneumonia].
    Saito A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of azithromycin activity against Legionella spp.
    Edelstein PH
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis.
    Dournon E; Rajagopalan P; Vilde JL; Pocidalo JJ
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():41-8. PubMed ID: 3458697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).
    Dowling JN; Weyant RS; Pasculle AW
    Antimicrob Agents Chemother; 1982 Aug; 22(2):272-6. PubMed ID: 6927637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.